The Bonnie J. Addario Lung Cancer Foundation
The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

Bonnie Addario in UCSF Lab
 

Archive for June, 2006

BioView to collaborate with MD Anderson on lung cancer

BioView Ltd., which develops and distributes automated scanning systems for the detection of cancer, has signed an agreement with the University of Texas MD Anderson Cancer Center, for the joint development of an early diagnosis system for lung cancer among high risk population groups.

 

No Comments | Trackback | Permalink

 

Cancer survivors wonder: What’s next?

Cancer doctors are doing a better job of keeping people alive, but some physicians, like Patricia Ganz of UCLA, say they need to vastly improve their care for all those survivors.

 

No Comments | Trackback | Permalink

 

Racial differences in lung cancer risks

Blacks who smoke up to a pack a day are far more likely than whites who smoke similar amounts to develop lung cancer, suggesting genes may help explain the racial differences long seen in the disease.

 

No Comments | Trackback | Permalink

 

Women with lung cancer may lack symptoms

A significant proportion of women with newly diagnosed lung cancer had normal lung function tests.

 

No Comments | Trackback | Permalink

 

Drug ‘smart bombs’ future of cancer therapy

Using combinations of “smart bomb” cancer drugs that target specific proteins and avoid the indiscriminate cell destruction of chemotherapy may be the wave of the future for cancer patients.

 

No Comments | Trackback | Permalink

 

Yoga can ease cancer treatment side effects

This article concerns women going through treatment for breast cancer and how they felt better when they tried yoga

 

No Comments | Trackback | Permalink

 

Gender disparity in lung cancer may hold clues

Lung cancer acts differently in women than in men, and major new studies are exploring if estrogen is a key reason.

 

No Comments | Trackback | Permalink

 

Cancer Combos

The next big step in targeted cancer drug development will be combination therapy, according to new data released at the meeting of the American Society of Clinical Oncology.

 

No Comments | Trackback | Permalink

 

Study shows few doctors refer lung cancer patients to oncologists

A survey of almost 700 Wisconsin primary care physicians found that only 11 percent would refer a patient whose lung cancer recurred to an oncologist, compared to 25 percent who said they’d refer a patient with advanced breast cancer.

 

No Comments | Trackback | Permalink

 

Method could help detect lung damage in smokers earlier

New technology could help doctors detect lung damage in smokers who seem healthy, say researchers at the University of Wisconsin-Madison.

 

No Comments | Trackback | Permalink